LSE:STX (Shield Therapeutics Plc)

Shield Therapeutics Plc (LSE: STX)
Latest News

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Shield Therapeutics’ share price is up 318% in 1 year! Should I buy now?

Shield Therapeutics' share price has more than QUADRUPLED in a year! But is it too late for investors to buy…

Read more »

Investing Articles

Prediction: these near-penny stocks could be among 2026’s big winners

Zaven Boyrazian breaks down two almost penny stocks that expert investors believe could surge next year, delivering between 35% and…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

At 6.6p, could this fast-growing penny stock be a millionaire-maker?

Mark Hartley is impressed by the growth trajectory and product pipeline of an upcoming pharma penny stock. But is it…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

2 growth stocks I’d never heard of — until they soared nearly 40% this week!

Two little-known FTSE shares, Shield Therapeutics and Pantheon Resources, soared up to 40% this week. Could these growth stocks keep…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

This 5p penny stock is crushing the stock market in 2025

This micro-cap share is outperforming global stock markets by tenfold this year! Mark Hartley investigates the company's prospects.

Read more »

Investing Articles

Should I buy these 2 penny stocks?

News coming out of these low-cost UK shares has been encouraging in recent months. Is now the time for me…

Read more »

Investing Articles

Here are two UK small-cap stocks I’d buy right now

Uk small-cap stocks can offer great returns but are often very risky. I think these two shares are worth a…

Read more »

Investing Articles

Why I’d ditch this high-risk growth share to buy British American Tobacco plc

After a sharp decline, British American Tobacco plc (LON:BATS) could be worth a fresh look.

Read more »

Investing Articles

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN)…

Read more »